We still pay for Agile (presumably mostly paid off now) and the EVT801 phase 1 trial. Other biotechs with a number of trials similar to Kazia have yearly cash burn over $100 million.
- Forums
- ASX - By Stock
- KZA Chart
We still pay for Agile (presumably mostly paid off now) and the...
-
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online